INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
SC

Skaff Michael C

10% OwnerCIK 0002074003

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells5 / 0
Max Insider Score50
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
47
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$576K
430.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Vivos Therapeutics, Inc.10% Owner · Apr 2, 2026
50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY
$2.39M
1.78M sh
Mar 31, 2026
Apr 2, 2026
traded Mar 31, 2026
+2d
SEC FORM 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$1.40M
1.04M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

43
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$414K
308.8K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence